Long-term safety follow-up of children from a randomized—controlled phase II b proof—of—concept efficacy study of the live, attenuated, tetravalent dengue vaccine (CYD—TDV) in Thailand

MLA

Kriengsak Limkittikul, et al. “Long-Term Safety Follow-up of Children from a Randomized—controlled Phase II b Proof—of—concept Efficacy Study of the Live, Attenuated, Tetravalent Dengue Vaccine (CYD—TDV) in Thailand.” Asian Pacific Journal of Tropical Medicine, vol. 12, no. 9, Jan. 2019, pp. 396–403. EBSCOhost, https://doi.org/10.4103/1995-7645.267582.

APA

Kriengsak Limkittikul, Weerawan Hattasingh, Danaya Chansinghakul, Arunee Sabchareon, Wut Dulyachai, Carina Frago, T Anh Wartel, Edith Langevin, Sophia Gailhardou, & Alain Bouckenooghe. (2019). Long-term safety follow-up of children from a randomized—controlled phase II b proof—of—concept efficacy study of the live, attenuated, tetravalent dengue vaccine (CYD—TDV) in Thailand. Asian Pacific Journal of Tropical Medicine, 12(9), 396–403. https://doi.org/10.4103/1995-7645.267582

Chicago

Kriengsak Limkittikul, Weerawan Hattasingh, Danaya Chansinghakul, Arunee Sabchareon, Wut Dulyachai, Carina Frago, T Anh Wartel, Edith Langevin, Sophia Gailhardou, and Alain Bouckenooghe. 2019. “Long-Term Safety Follow-up of Children from a Randomized—controlled Phase II b Proof—of—concept Efficacy Study of the Live, Attenuated, Tetravalent Dengue Vaccine (CYD—TDV) in Thailand.” Asian Pacific Journal of Tropical Medicine 12 (9): 396–403. doi:10.4103/1995-7645.267582.